EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Homozygous Founder ELAC2 Variant in Kuwaiti Infants With Fatal Cardiomyopathy and Refractory Severe Lactic Acidosis: A Retrospective Review of the Clinical, Cardiological and Molecular Findings

Hind Alsharhan iD, Worood Alostad, Alshaymaa A Ali iD, Mohammad A Ebrahim iD, Hesham A F Mohammed iD, Ahmad Alahmad iD, Hashem Alhashemi, Walid M Hassan iD, Ahmad E M S Alhaj, Rasha M Alsafi, Buthaina Albash iD

Molecular Genetics & Genomic Medicine · 2026-07 · 14 (7)

DOI: 10.1002/mgg3.70274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 20.07.2026. Verfasst von Hind Alsharhan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Health Sciences Centre, College of Medicine, Kuwait University, Safat, Kuwait. Hauptthemen laut MEDLINE: Acidosis, Lactic, Cardiomyopathies. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infantile‐onset cardiomyopathy due to mitochondrial dysfunction is a severe condition frequently associated with poor prognosis. Biallelic pathogenic variants in ELAC2 , an essential mitochondrial tRNA processing gene, have been implicated in this phenotype. This study investigates the clinical and genetic spectrum of ELAC2 ‐related disease in a national cohort from Kuwait.

Methods

We conducted a retrospective cohort study using data from the Kuwait Medical Genetics Center registry, including individuals with genetically confirmed or clinically suspected ELAC2 ‐related cardiomyopathy. Clinical, metabolic, and molecular data were reviewed. Exome sequencing or targeted mutation testing was performed in affected individuals and at‐risk family members.

Results

A total of 34 individuals from 23 consanguineous families were identified, of whom 30 were genetically confirmed to harbor the homozygous ELAC2 founder variant c.460T>C; p.(Phe154Leu). All individuals presented in infancy with severe cardiomyopathy and refractory lactic acidosis. Neurological involvement was observed in 39% of cases. The majority exhibited hypertrophic cardiomyopathy, with variable dilated features and pericardial effusion. The disease course was fatal in all, with most patients dying in infancy.

Conclusion

This is the largest single‐country cohort reported to date with ELAC2 ‐related mitochondrial cardiomyopathy, raising the global case total to over 70. The uniform presence of the Phe154Leu variant across unrelated Bedouin families highlights a strong founder effect. Given the rapid disease progression and high mortality, we recommend targeted ELAC2 screening in infants with idiopathic cardiomyopathy and persistent lactic acidosis, particularly in consanguineous populations. Premarital carrier testing and early family counseling should be prioritized to support preventive strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acidosis, LacticCardiomyopathiesHumansFemaleMaleInfantKuwaitHomozygoteRetrospective StudiesFounder EffectMutationConsanguinityInfant, NewbornPhenotypePedigreeNeoplasm Proteins

Stichwörter der Autor:innen

ELAC2Kuwaitconsanguinitydilated cardiomyopathyfounder mutationhypertrophic cardiomyopathylactic acidosismitochondrial diseasepericardial effusion

Substanzen

ELAC2 protein, humanNeoplasm Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, Health Sciences Centre, College of Medicine, Kuwait University, Safat, Kuwait.
  • Kuwait Medical Genetics Center, Ministry of Health, Sulaibikhat, Kuwait.
  • Department of Pediatrics, Farwaniya Hospital, Ministry of Health, Sabah Al-Nasser, Kuwait.
  • Department of Pediatrics, Jaber Al-Ahmad Hospital, Ministry of Health, Kuwait, Kuwait.
  • Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
  • Cardiology Department, Chest Hospital, Ministry of Health, Kuwait, Kuwait.

ORCID-Profile: Hind Alsharhan, Alshaymaa A Ali, Mohammad A Ebrahim, Hesham A F Mohammed, Ahmad Alahmad, Walid M Hassan, Buthaina Albash

Zitieren

APA

Alsharhan, H., Alostad, W., Ali, A. A., Ebrahim, M. A., Mohammed, H. A. F., Alahmad, A., Alhashemi, H., Hassan, W. M., Alhaj, A. E. M. S., Alsafi, R. M., & Albash, B. (2026). A Homozygous Founder ELAC2 Variant in Kuwaiti Infants With Fatal Cardiomyopathy and Refractory Severe Lactic Acidosis: A Retrospective Review of the Clinical, Cardiological and Molecular Findings. Molecular Genetics & Genomic Medicine, 14(7). https://doi.org/10.1002/mgg3.70274

Vancouver

Alsharhan H, Alostad W, Ali AA, Ebrahim MA, Mohammed HAF, Alahmad A, et al. A Homozygous Founder ELAC2 Variant in Kuwaiti Infants With Fatal Cardiomyopathy and Refractory Severe Lactic Acidosis: A Retrospective Review of the Clinical, Cardiological and Molecular Findings. Molecular Genetics & Genomic Medicine. 2026;14(7). doi:10.1002/mgg3.70274

BibTeX
@article{Alsharhan2026,
  author = {Alsharhan, Hind and Alostad, Worood and Ali, Alshaymaa A and Ebrahim, Mohammad A and Mohammed, Hesham A F and Alahmad, Ahmad and Alhashemi, Hashem and Hassan, Walid M and Alhaj, Ahmad E M S and Alsafi, Rasha M and Albash, Buthaina},
  title = {A Homozygous Founder ELAC2 Variant in Kuwaiti Infants With Fatal Cardiomyopathy and Refractory Severe Lactic Acidosis: A Retrospective Review of the Clinical, Cardiological and Molecular Findings},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  volume = {14},
  number = {7},
  doi = {10.1002/mgg3.70274}
}
Kostenlos starten →